Protective effect of dl-α-lipoic acid on cyclophosphamide induced hyperlipidemic cardiomyopathy

European Journal of Pharmacology

Volumn 543, Issue 1-3, 2006, Pages 92-96

  Mythili, Yenjerla ^a   Sudharsan, Periyasamy Thandavan ^a   Sudhahar, Varatharajan ^a   Varalakshmi, Palaninathan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Cyclophosphamide; Heart; Hyperlipidemia; Lipoic acid; Serum

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; CHOLESTEROL ESTER; CYCLOPHOSPHAMIDE; ENZYME; FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; THIOCTIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; CARDIOTOXICITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; HEART; HEART PROTECTION; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; CARDIOMYOPATHIES; CHOLESTEROL ESTERASE; CYCLOPHOSPHAMIDE; HYPERLIPIDEMIAS; LIPID METABOLISM; LIPIDS; LIPOPROTEIN LIPASE; LIPOPROTEINS; MALE; MYOCARDIUM; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; RATS; RATS, WISTAR; STEROL ESTERASE; THIOCTIC ACID;

EID: 33746210028     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.007     Document Type: Article

References (38)

1. Angelucci L., and Mastelli-Coriandoli E. Anticholesterol activity of lipoic acid. Nature 181 (1958) 911-918
2. Arikketh D., Niranjali S., and Devaraj H. Detection of acrolein-lysine adducts in plasma low-density lipoprotein and in aorta of cyclophosphamide-administered rats. Arch. Toxicol. 78 (2004) 397-401
3. Boren J., Veniant M.M., and Young S.G. Apo B100-containing lipoproteins are secreted by the heart. J. Clin. Invest. 101 (1998) 1197-1202
4. Bustamante J., Lodge J.K., Marcocci L., Tritschler H.J., Packer L., and Rihn B.H. Alpha-lipoic acid in liver metabolism and disease. Free Radic. Biol. Med. 24 (1998) 1023-1039
5. Dollery C. Cyclophosphamide. In: Dollery C. (Ed). Therapeutic Drugs (1999), Churchill Livingstone, Edinburg 349-353
6. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
7. Ford I., Cotter M.A., Cameron N.E., and Greaves M. The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism 50 (2001) 868-875
8. Fraiser L.H., Kanekal S., and Kehrer J.P. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 42 (1991) 781-795
9. Gesquiere L., Loreau N., Minnich A., Davignon J., and Blache D. Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radic. Biol. Med. 27 (1999) 134-145
10. Goldberg M.A., Antin J.H., Guinan E.C., and Rappeport J.M. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 68 (1986) 1114-1118
11. Hitz J., Steinmetz J., and Siest G. Plasma lecithin:cholesterol acyltransferase - reference values and effects of xenobiotics. Clin. Chim. Acta 133 (1983) 85-96
12. Hron W.T., and Menahan L.A. A sensitive method for the determination of free fatty acids in plasma. J. Lipid Res. 22 (1981) 377-381
13. Kagan V.E., Shvedova A., Serbinova E., Khan S., Swanson C., Powell R., and Packer L. Dihydrolipoic acid-a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem. Pharmacol. 44 (1992) 1637-1649
14. Kothari H.V., Bonner M.J., and Miller B.F. Cholesterol ester hydrolase in homogenates and lysosomal fractions of human aorta. Biochim. Biophys. Acta 202 (1970) 325-331
15. Kothari H.V., Miller B.F., and Kritchevsky D. Aortic cholesterol esterase: characteristics of normal rat and rabbit enzyme. Biochim. Biophys. Acta 296 (1973) 446-454
16. Kritchevsky D., and Kothari H.V. Aortic cholesterol esterase: studies in White Carneau and Show Racer pigeons. Biochim. Biophys. Acta 326 (1973) 489-491
17. Lee C.K., Harman G.S., Hohl R.J., and Gingrich R.D. Fatal cyclophosphamide cardiomyopathy: its clinical course and treatment. Bone Marrow Transplant. 18 (1996) 573-577
18. Legrand A., Guillansseav R.J., and Land J. Method of colorimetric simple determination det activity dela lecithin cholesterol acyl transferase (LCAT) plasmitque. Entrust on diabetoelogic. In: Siest G., and Glatean M.M. (Eds). Biologic Perspective (1979), Masson, Paris 368-371
19. Lespine A., Dousset N., Perret B., De Forni M., Chap H., and Douste-Blazy L. Accumulation of large VLDL in cyclophosphamide treated rabbits. Relationship with lipoprotein lipase deficiency. Biochem. Biophys. Res. Commun. 154 (1988) 633-640
20. Lespine A., Azema C., Gafvels M., Manent J., Dousset N., Chap H., and Perret B. Lipoprotein lipase regulation in the cyclophosphamide-treated rabbit: dependence on nutritional status. J. Lipid Res. 34 (1993) 23-36
21. Lespine A., Chap H., and Perret B. Impaired secretion of heart lipoprotein lipase in cyclophosphamide-treated rabbit. Biochim. Biophys. Acta 1345 (1997) 77-85
22. Loudet A.M., Dousset N., Carton M., and Douste-Blazy L. Effects of an antimitotic agent (cyclophosphamide) on plasma lipoproteins. Biochem. Pharmacol. 33 (1984) 2961-2965
23. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
24. McClure M.T., and Stupans I. Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male rats. Biochem. Pharmacol. 43 (1992) 2655-2658
25. Muralikrishnan G., Amalan Stanley V., and Pillai K. Dual role of vitamin C on lipid profile and combined application of cyclophosphamide, methotrexate and 5-fluorouracil treatment in fibrosarcoma-bearing rats. Cancer Lett. 169 (2001) 115-120
26. Mythili Y., Sudharsan P.T., Selvakumar E., and Varalakshmi P. Protective effect of dl-alpha-lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem. Biol. Interact. 151 (2004) 13-19
27. Packer L., Witt E.H., and Tritschler H.J. alpha-Lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19 (1995) 227-250
28. Parekh A.C., and Jung D.H. Cholesterol determination with ferric acetate-uranium acetate and sulphuric acid-ferrous sulphate reagents. Biochim. Biophys. Acta 42 (1970) 1423-1427
29. Proudlock J.W., and Day A.J. Cholesterol esterifying enzymes of atherosclerotic rabbit intima. Biochim. Biophys. Acta 260 (1972) 716-723
30. Rice, E.W., 1970. Triglycerides (neutral fats) in serum. In: Mac-Donald, R.P. (Ed), Standard methods of clinical chemistry. Academic Press, New York. pp. 6, 215-222.
31. Rouser G., Fkeischer S., and Yamamoto A. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5 (1970) 494-496
32. Schimmel K.J., Richel D.J., Van den Brink R.B., and Guchelaar H.J. Cardiotoxicity of cytotoxic drugs. Cancer Treat. Rev. 30 (2004) 181-191
33. Schmidt A. Measurement of lipoprotein lipase and hepatic triglyceride lipase. Methods Enzymol. 72 (2000) 325-337
34. Sperry W.M., and Webb M. A revision of the Schoenheimer-Sperry method for cholesterol determination. J. Biol. Chem. 187 (1950) 97-106
35. Struck R.F., Kari P., Kalin J., Montgomery J.A., Marinello A.J., Love J., Bansal S.K., and Gurtoo H.L. Metabolism of cyclophosphamide by purified cytochrome P-450 from microsomes of phenobarbital-treated rats. Biochem. Biophys. Res. Commun. 120 (1984) 390-396
36. Subramanian R., Ramaswamy M., and Wasan K.M. Role of lipid and lipoprotein metabolizing enzymes in the development of atherosclerosis. Indian J. Exp. Biol. 41 (2003) 14-25
37. Wilson D.E., and Spiger M.J. A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation. J. Lab. Clin. Med. 82 (1973) 473-482
38. Yang Q., and Cheng L. Molecular regulation of lipotoxicity in the heart. Drug Discov. Today: Dis. Mech. 2 (2005) 101-107